COVID-19

Showing NaN - NaN of 65

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Denmark, United States (PF-07304814, Placebo, Remdesivir)

Suspended
  • COVID-19
  • Chula Vista, California
  • +39 more
Mar 22, 2023

COVID-19 Trial in United States (drug, biological, other)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +21 more
Feb 2, 2023

COVID-19 Trial in Boston (vitamin D, Placebo)

Active, not recruiting
  • COVID-19
  • vitamin D
  • Placebo
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 25, 2023

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

Atrial Fibrillation, COVID-19, Cancer Trial in Boston (drug, device, procedure)

Recruiting
  • Atrial Fibrillation
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

COVID-19 Trial in United States (other, drug, biological)

Completed
  • COVID-19
  • Placebo
  • +2 more
  • Tucson, Arizona
  • +31 more
Nov 23, 2022

COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)

Completed
  • COVID-19
  • +2 more
  • pathogen reduced SARS-CoV-2 convalescent plasma
  • Placebo
  • Little Rock, Arkansas
  • +25 more
Oct 6, 2022

Infection Viral, Thromboses, Venous, COVID-19 Trial in United States (Enoxaparin Prefilled Syringe [Lovenox])

Completed
  • Infection Viral
  • +2 more
  • Enoxaparin Prefilled Syringe [Lovenox]
  • Birmingham, Alabama
  • +15 more
Sep 15, 2022

COVID-19, Stress, Shortness of Breath Trial in Boston (Breathing and Wellness Webinar, Routine Daily Activity)

Enrolling by invitation
  • COVID-19
  • +2 more
  • Breathing and Wellness Webinar
  • Routine Daily Activity
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Centre
Oct 6, 2022

SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

Completed
  • SARS-CoV Infection
  • +3 more
  • Moderna COVID-19 Vaccine
  • +2 more
  • Tucson, Arizona
  • +28 more
Sep 19, 2022

COVID-19 Trial in United States (Lopinavir/Ritonavir 400 mg/100 mg, Placebo)

Active, not recruiting
  • COVID-19
  • Lopinavir/Ritonavir 400 mg/100 mg
  • Placebo
  • Aurora, Colorado
  • +5 more
Aug 17, 2022

COVID-19 Trial in Worldwide (Remdesivir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +36 more
Aug 18, 2022

Acute Respiratory Distress Syndrome, COVID-19 Trial in United States (Brexanolone, Placebo)

Terminated
  • Acute Respiratory Distress Syndrome
  • COVID-19
  • Fresno, California
  • +8 more
Aug 17, 2022

COVID-19, SARS-CoV-2 Trial in United States (Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin)

Terminated
  • COVID-19
  • SARS-CoV-2
  • Ascorbic Acid
  • +4 more
  • Chicago, Illinois
  • +5 more
Jul 12, 2022

COVID-19 Trial in Worldwide (nirmatrelvir, ritonavir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +94 more
Aug 2, 2022

COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)

Completed
  • COVID-19
  • Lenzilumab
  • +2 more
  • Birmingham, Alabama
  • +55 more
Jul 21, 2022

COVID-19 Trial in United States (Danicopan, Placebo, Remdesivir)

Completed
  • COVID-19
  • Birmingham, Alabama
  • +38 more
Jul 21, 2022

COVID-19, COVID Trial in Boston (Pegylated interferon lambda)

Terminated
  • COVID-19
  • COVID
  • Pegylated interferon lambda
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 29, 2022

COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • AZD1222
  • Placebo
  • Phoenix, Arizona
  • +83 more
Jul 13, 2022